Minerva Neurosciences
NERV
NERV
21 hedge funds and large institutions have $5.42M invested in Minerva Neurosciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
64% less capital invested
Capital invested by funds: $14.9M → $5.42M (-$9.48M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$182K | |
| 2 | +$121K | |
| 3 | +$90.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$43K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.08K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$4.9K | |
| 3 | -$4.71K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$143 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8 |